Dendritic Cell-Derived Artificial Microvesicles Inhibit RLS<sub>40</sub> Lymphosarcoma Growth in Mice via Stimulation of Th1/Th17 Immune Response
Cell-free antitumor vaccines represent a promising approach to immunotherapy of cancer. Here, we compare the antitumor potential of cell-free vaccines based on microvesicles derived from dendritic cells (DCs) with DC- and cationic-liposome-based vaccines using a murine model of drug-resistant lympho...
Main Authors: | Oleg V. Markov, Aleksandra V. Sen’kova, Islam S. Mohamed, Elena V. Shmendel, Mikhail A. Maslov, Anastasiya L. Oshchepkova, Evgeniy V. Brenner, Nadezhda L. Mironova, Marina A. Zenkova |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/11/2542 |
Similar Items
-
Concurrent lymphosarcoma and Salmonella enteritidis infection in a cat: a case report
by: M.I. Bhaiyat, et al.
Published: (2009-09-01) -
Modeling of the multidrug resistance syndrome in experiment on mice with lymphosarcoma RLS<sub>40</sub>
by: A. V. Sen’kova, et al.
Published: (2008-12-01) -
DNA damage of blood lymphocytes and neutrophils in cattle with lymphosarcoma
by: T. Mohamed, et al.
Published: (2011-10-01) -
JUVENILE LYMPHOSARCOMA IN CALF: A CYTOHISTOLOGICALANALYSIS
by: Shafiqur Rahman, et al.
Published: (2023-06-01) -
Single Shot vs. Cocktail: A Comparison of Mono- and Combinative Application of miRNA-Targeted Mesyl Oligonucleotides for Efficient Antitumor Therapy
by: Svetlana Gaponova, et al.
Published: (2022-09-01)